BAAM
INSP icon

Baker Avenue Asset Management’s Inspire Medical Systems INSP Stock Holding History

Baker Avenue Asset Management’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-201
Closed -$39.9K – 898
2023
Q3 		$39.9K Sell
201
-2
-1% -$504 ﹤0.01% 553
2023
Q2 		$65.9K Buy
203
+200
+6,667% +$57.1K ﹤0.01% 490
2023
Q1 		$702 Hold
3
– – ﹤0.01% 1303
2022
Q4 		$756 Buy
+3
New +$640 ﹤0.01% 1195

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Baker Avenue Asset Management's INSP Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Inspire Medical Systems (INSP) in Q4 2023, closing a stake of 201 shares — an estimated $39.9K sold.

Baker Avenue Asset Management first reported a position in INSP in Q4 2022 and held it in 4 quarters. The position peaked at $65.9K in Q2 2023. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Inspire Medical Systems position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 201 Inspire Medical Systems shares in Q4 2023, an estimated $39.9K.
  • Baker Avenue Asset Management first reported a position in Inspire Medical Systems in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's Inspire Medical Systems position peaked at $65.9K in Q2 2023.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.